Allows the growth, cultivation, and adult use of psilocybin for the treatment of certain health conditions
download bill text pdf| Date of Action |
Assembly Actions -
Lowercase Senate Actions - UPPERCASE |
|---|---|
| May 21, 2024 |
referred to health |
S T A T E O F N E W Y O R K
________________________________________________________________________
10375
I N A S S E M B L Y
May 21, 2024
___________
Introduced by COMMITTEE ON RULES -- (at request of M. of A. Paulin) --
read once and referred to the Committee on Health
AN ACT to amend the public health law, in relation to promoting the
health and well-being of the citizens of the state of New York by
establishing a comprehensive framework supporting public health and
safety through regulated adult use, support services, and cultivation
of psilocybin-containing fungi
THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:
Section 1. Article 33 of the public health law is amended by adding a
new title 5-B to read as follows:
TITLE V-B
REGULATED HEALTH ACCESS AND SUPPORT SERVICES FOR PSILOCYBIN ACT
SECTION 3369-AA. DEFINITIONS.
3369-BB. REGULATION OF PSILOCYBIN PROGRAMS.
3369-CC. REGULATED ADULT USE OF PSILOCYBIN IN CONNECTION WITH
PUBLIC HEALTH FRAMEWORK.
3369-DD. CERTIFICATION AND AUTHORIZED SERVICES OF SUPPORT
SERVICES PROVIDER.
3369-EE. CULTIVATOR LICENSE AND REQUIREMENTS.
3369-FF. RELATION TO OTHER LAWS.
3369-GG. PROTECTIONS.
3369-HH. REGULATED PSILOCYBIN ADVISORY BOARD.
3369-II. TAXATION OF PSILOCYBIN REGULATED ACTIVITIES.
§ 3369-AA. DEFINITIONS. FOR THE PURPOSES OF THIS TITLE, THE FOLLOWING
TERMS SHALL HAVE THE FOLLOWING MEANINGS:
1. "BUSINESS ENTERPRISE" MEANS ANY ENTITY, INCLUDING A SOLE PROPRIE-
TORSHIP, PARTNERSHIP, LIMITED LIABILITY PARTNERSHIP, LIMITED LIABILITY
COMPANY OR CORPORATION, INCLUDING NOT-FOR-PROFIT CORPORATIONS, WHICH IS
AUTHORIZED TO AND ENGAGES IN LAWFUL BUSINESS TRANSACTIONS IN ACCORDANCE
WITH NEW YORK LAW.
2. "ADULT USE OF PSILOCYBIN" MEANS THE AUTHORIZED ADULT, NON-COMMER-
CIAL USE OF PSILOCYBIN IN CONNECTION WITH A PUBLIC HEALTH FRAMEWORK AS
PROVIDED UNDER THIS TITLE.
EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD15437-03-4 A. 10375 2 3. "CULTIVATOR LICENSE" MEANS A WRITTEN AUTHORIZATION PERMITTING NATURAL PERSONS OR BUSINESS ENTERPRISES TO ENGAGE IN THE SPECIFIED ACTIVITIES OF CULTIVATION, DISTRIBUTION, AND TESTING OF PSILOCYBIN, AS AUTHORIZED PURSUANT TO THIS TITLE. ONLY A PERSON OR BUSINESS ENTERPRISE WITH A CULTIVATOR LICENSE MAY ENGAGE IN COMMERCIAL TRANSACTIONS WITH PSILOCYBIN-CONTAINING FUNGI. 4. "DEPARTMENT" SHALL MEAN NEW YORK STATE DEPARTMENT OF HEALTH. 5. "EXCLUSION CRITERIA" MEANS CERTAIN HEALTH CONDITIONS, PRESCRIPTION MEDICATIONS, OR CONSUMPTION OF OTHER SUBSTANCES THAT, BASED ON CURRENTLY AVAILABLE MEDICAL INFORMATION AND RESEARCH, ARE CONTRAINDICATED OR HAVE A RISK OF NEGATIVE INTERACTION WITH THE USE OF PSILOCYBIN. EXCLUSION CRITERIA SHALL BE ADDED OR REMOVED BY THE DEPARTMENT. 6. "HEALTH SCREENING" MEANS A SCREENING FORM TO ALLOW A PERSON TO CERTIFY SYMPTOMS OR PRIOR OR CURRENT DIAGNOSIS OF ONE OR MORE HEALTH CONDITIONS OR EXCLUSION CRITERIA. 7. "LICENSED HEALTHCARE PROVIDER" MEANS A PERSON WITH A VALID LICENSE OR CERTIFICATE FROM THE DEPARTMENT OF EDUCATION FOR A PROFESSION PROVIDED IN ARTICLE ONE HUNDRED THIRTY-ONE, ONE HUNDRED THIRTY-TWO, ONE HUNDRED THIRTY-SIX, ONE HUNDRED THIRTY-NINE, ONE HUNDRED FORTY, ONE HUNDRED FORTY-ONE, ONE HUNDRED FORTY-THREE, ONE HUNDRED FIFTY-THREE, ONE HUNDRED FIFTY-FOUR, ONE HUNDRED FIFTY-SEVEN, ONE HUNDRED FIFTY-NINE, ONE HUNDRED SIXTY, ONE HUNDRED SIXTY-THREE, ONE HUNDRED SIXTY-FOUR, OR ONE HUNDRED SIXTY-SEVEN OR OTHERWISE RELATED TO WELLNESS, MEDICINE, HEALTH- CARE, MENTAL HEALTH, OR BEHAVIORAL HEALTH. TO BE A LICENSED HEALTHCARE PROVIDER UNDER THIS TITLE, SUCH LICENSED PROFESSIONAL'S AUTHORIZED SCOPE OF PRACTICE DOES NOT NEED TO BUT MAY INCLUDE MEDICAL DIAGNOSIS OR PRESCRIPTION OF MEDICATIONS. 8. "HEALTH CONDITIONS" MEAN CERTAIN HEALTH CONDITIONS THAT INCLUDE BUT ARE NOT LIMITED TO: (A) ADJUSTMENT DISORDER; (B) AMYOTROPHIC LATERAL SCLEROSIS; (C) ATTENTION DEFICIT/HYPERACTIVITY DISORDER; (D) ARTHRITIS; (E) AUTISM; (F) ALZHEIMER'S; (G) ANXIETY; (H) ANOREXIA NERVOSA; (I) BACTERIAL INFECTION OR DISEASE; (J) BEHAVIORAL/PROCESS ADDICTION, INCLUDING GAMBLING, PORNOGRAPHY, OR SHOPPING; (K) BODY DYSMORPHIA; (L) CATARACTS; (M) CANCER; (N) CANCER-RELATED DISTRESS; (O) CHRONIC PAIN; (P) CHRONIC FATIGUE; (Q) CLUSTER HEADACHES; (R) DEPRESSIVE DISORDER; (S) DEGENERATIVE DISC OR JOINT DISEASE; (T) EATING DISORDER; (U) EFFECTS FROM STROKE; (V) EPILEPSY; (W) EPISODIC MIGRAINES; (X) FIBROMYALGIA; (Y) FUNCTIONAL GASTROINTESTINAL DISORDER, INCLUDING IRRITABLE BOWEL SYNDROME (IBS) AND INFLAMMATORY BOWEL DISEASE (IBD); A. 10375 3 (Z) GLAUCOMA; (AA) HEADACHE DISORDERS; (BB) HIV/AIDS; (CC) INSOMNIA; (DD) LYME DISEASE; (EE) MOOD DISORDER; (FF) MOTOR NEURON DISEASE; (GG) MIGRAINE; (HH) MULTIPLE SCLEROSIS; (II) MUSCULAR DYSTROPHY; (JJ) NEURODEGENERATIVE DISEASE INCLUDING NEUROPATHY; (KK) OBSESSIVE-COMPULSIVE DISORDER; (LL) PARKINSON'S DISEASE; (MM) PANIC DISORDER; (NN) PARESTHESIA; (OO) PHANTOM LIMB PAIN; (PP) PREMENSTRUAL SYNDROME OR PREMENSTRUAL DYSPHORIC DISORDER; (QQ) PROLONGED GRIEF DISORDER; (RR) POSTPARTUM MENTAL HEALTH DISORDER; (SS) POST-ACUTE COVID-19 INFECTION CONDITION; (TT) POST-TRAUMATIC STRESS DISORDER (PTSD) OR COMPLEX POST-TRAUMATIC STRESS DISORDER; (UU) PSYCHOGENIC PAIN DISORDER; (VV) RESTLESS LEG SYNDROME; (WW) RHEUMATOID ARTHRITIS; (XX) SEXUAL DISORDER; (YY) SENSORY PROCESSING DISORDER; (ZZ) SLEEP DISORDER; (AAA) SUBSTANCE USE DISORDER, INCLUDING FOR USE OF OPIATES, TOBACCO, AND ALCOHOL; (BBB) TERMINAL ILLNESS OR END-OF-LIFE DISTRESS; (CCC) TRAUMATIC BRAIN INJURY (TBI), INCLUDING CONCUSSION; (DDD) TREATMENT RESISTANT DEPRESSION; (EEE) UNSPECIFIED MOOD DISORDER; AND (FFF) ANY NOVEL OR EMERGENT HEALTH CONDITION NOT CATEGORIZED IN THE DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS OR KNOWN PHYSICAL HEALTH CONDITIONS WHERE THERE IS EVIDENCE OF POTENTIAL USE OF PSILOCYBIN WITH POSITIVE OUTCOMES IN CONNECTION WITH SUCH HEALTH CONDITIONS THAT HAS BEEN IDENTIFIED IN A STUDY PUBLISHED IN A MEDICAL OR SCIENTIFIC JOURNAL, INCLUDING PREPRINT SERVERS. 9. "LICENSED CULTIVATOR" MEANS A PERSON OR BUSINESS ENTERPRISE, INCLUDING A SOLE PROPRIETORSHIP, PARTNERSHIP, CORPORATION, LIMITED LIABILITY COMPANY, OR OTHER BUSINESS ENTERPRISE, THAT POSSESSES A CULTI- VATOR LICENSE PURSUANT TO THIS TITLE. 10. "NONCOMMERCIAL" MEANS AN ACTION OR TRANSACTION OF GOODS THAT IS WITHOUT REMUNERATION OR THE EXCHANGE OF MONEY. 11. "PERMIT COURSE" MEANS THE PSILOCYBIN REGULATION EDUCATIONAL PERMIT (PREP) COURSE THAT INCLUDES EDUCATIONAL MATERIAL AND A TEST THAT MUST BE SUCCESSFULLY COMPLETED BY A PERSON WHO HAS RECEIVED A HEALTH SCREENING AND IS APPLYING FOR A PSILOCYBIN PERMIT. THERE WILL BE NO LIMIT IN THE NUMBER OF ATTEMPTS TO COMPLETE THE TEST COMPONENT OF THE PERMIT COURSE IN ORDER TO RECEIVE A PSILOCYBIN PERMIT, AS THE PURPOSE OF SUCH TEST IS TO ENABLE EDUCATION AND INFORMATION TO INCREASE SAFETY OF ADULT USE OF PSILOCYBIN. 12. "PERSON" MEANS A NATURAL PERSON. A. 10375 4 13. "PSILOCYBIN" MEANS FUNGI THAT CONTAIN NATURALLY-OCCURRING PSILOCY- BIN AND PSILOCIN COMPOUNDS PRODUCED BY SUCH FUNGI, INCLUDING BUT NOT LIMITED TO MEMBERS OF THE GENUS PSILOCYBIN. 14. "PSILOCYBIN PERMIT" MEANS A WRITTEN AUTHORIZATION FROM THE DEPART- MENT ISSUED TO A PERSON AT LEAST EIGHTEEN YEARS OLD WHO HAS RECEIVED A HEALTH SCREENING AND SUCCESSFULLY COMPLETED THE PERMIT COURSE TO ALLOW ADULT USE OF PSILOCYBIN IN CONNECTION WITH A PUBLIC HEALTH FRAMEWORK. 15. "SCHOOL GROUNDS" MEANS ANY BUILDING, STRUCTURE, AND SURROUNDING OUTDOOR GROUNDS, INCLUDING ENTRANCES OR EXITS, CONTAINED WITHIN A PUBLIC OR PRIVATE PRE-SCHOOL, NURSERY SCHOOL, ELEMENTARY OR SECONDARY SCHOOL'S LEGALLY DEFINED PROPERTY BOUNDARIES AS REGISTERED IN A COUNTY CLERK'S OFFICE. 16. "SUPPORT SERVICES" MEAN THE SERVICES CONSISTENT WITH THIS TITLE THROUGH ACTIONS OF SUPPORTIVE CARE AND RESPONSE TO ADVERSE HEALTH CIRCUMSTANCES, PROVISION OF EDUCATIONAL INFORMATION, AND OTHER CONDUCT PROVIDED BY A CERTIFIED SUPPORT SERVICES PROVIDER THAT INCREASE THE SAFETY AND REDUCE POTENTIAL RISKS ASSOCIATED WITH A PSILOCYBIN PERMIT HOLDER'S AUTHORIZED USE OF PSILOCYBIN. 17. "SUPPORT SERVICES PROVIDER CERTIFICATION" MEANS A CERTIFICATION THAT IS REGULATED AND ISSUED BY THE DEPARTMENT THAT AUTHORIZES THE SUPPORT SERVICES OF A SUPPORT SERVICES PROVIDER. 18. "SUPPORT SERVICES PROVIDER" MEANS A PERSON WHO HAS BEEN GRANTED A CERTIFICATION TO PROVIDE RISK REDUCTION SUPPORT SERVICES, UPON COMPLETION AND CONTINUED SATISFACTION OF ALL REQUIREMENTS UNDER SECTION THIRTY-THREE HUNDRED SIXTY-NINE-CC OF THIS TITLE, INCLUDING ONGOING EDUCATION AND TRAINING IN CONNECTION WITH A PERMIT HOLDER'S ADULT USE OF PSILOCYBIN. § 3369-BB. REGULATION OF PSILOCYBIN PROGRAMS. 1. THE DEPARTMENT SHALL MANAGE ALL OPERATIONS OF THIS TITLE. 2. THE DEPARTMENT SHALL PROMULGATE REGULATIONS TO IMPLEMENT THIS TITLE. 3. THE DEPARTMENT MAY PROVIDE FOR THE ANALYSIS AND EVALUATION OF THE OPERATION OF THIS TITLE. THE DEPARTMENT MAY ENTER INTO AGREEMENTS WITH ONE OR MORE PERSONS, NOT-FOR-PROFIT CORPORATIONS, UNIVERSITIES, OR OTHER ORGANIZATIONS, FOR THE PERFORMANCE OF AN EVALUATION OF THE IMPLEMENTA- TION AND EFFECTIVENESS OF THIS TITLE. 4. THE DEPARTMENT SHALL BE RESPONSIBLE FOR REGULATING THE ADULT USE OF PSILOCYBIN WITH A PERMIT, CULTIVATION LICENSES AND LICENSED CULTIVATOR OPERATION REQUIREMENTS, CERTIFICATION OF SUPPORT SERVICES PROVIDERS, AND OTHER AUTHORIZED AND RELATED PROGRAMS. 5. THE DEPARTMENT SHALL CREATE A REPORTING PROGRAM TO ALLOW PERMIT HOLDERS THE OPTIONAL OPPORTUNITY TO IDENTIFY HEALTH AND EXPERIENCE DATA IN CONNECTION WITH ADULT USE OF PSILOCYBIN, INCLUDING ON HEALTH CONDI- TIONS AND POTENTIAL EXCLUSION CRITERIA, AND ALSO TO MAKE REPORTS ABOUT CERTIFIED SUPPORT SERVICES PROVIDERS AND THE PROVISION OF ETHICAL SERVICES. 6. THE DEPARTMENT SHALL REPORT EVERY TWO YEARS, BEGINNING TWO YEARS AFTER THE EFFECTIVE DATE OF THIS TITLE, TO THE GOVERNOR AND THE LEGISLA- TURE ON THE REGULATED ACCESS OF PSILOCYBIN UNDER THIS TITLE AND MAKE APPROPRIATE RECOMMENDATIONS. § 3369-CC. REGULATED ADULT USE OF PSILOCYBIN IN CONNECTION WITH PUBLIC HEALTH FRAMEWORK. A PSILOCYBIN PERMIT HOLDER SHALL BE PERMITTED TO ENGAGE IN THE ADULT USE OF PSILOCYBIN IN CONNECTION WITH QUALIFYING HEALTH CONDITIONS, PROVIDED THAT: 1. A PERSON SHALL BE PROVIDED A PSILOCYBIN PERMIT UPON COMPLETION OF A HEALTH SCREENING AND THE PERMIT COURSE. A. 10375 5 2. A PERSON SHALL COMPLETE A HEALTH SCREENING THAT CERTIFIES SYMPTOMS OR DIAGNOSIS OF ANY HEALTH CONDITIONS AND NO EXISTENCE OF EXCLUSION CRITERIA. 3. A HEALTH SCREENING SHALL INCLUDE A STRUCTURED SCREENING PROCESS WITH A FORM WHERE A PERSON APPLYING FOR A PSILOCYBIN PERMIT SELF-REPORTS SYMPTOMS OR DIAGNOSIS THAT INDICATE ANY HEALTH CONDITION OR EXCLUSION CRITERIA. 4. A HEALTH SCREENING FORM SHALL BE UPDATED BY THE PERMIT HOLDER IF THERE ARE ANY CHANGES TO THE CERTIFICATIONS OF HEALTH CONDITIONS, INCLUDING ANY NEW SYMPTOMS OR DIAGNOSIS, THAT CONSTITUTE EXCLUSION CRITERIA ON THE FORM FILED WITH THE DEPARTMENT AND RECOMPLETED BIENNIAL- LY TO MAINTAIN THE PSILOCYBIN PERMIT. ANY CHANGES TO SUCH FORM SHALL NOT PRECIPITATE A REQUIREMENT TO ENGAGE IN THE PERMIT COURSE UNTIL THE FOUR YEAR REQUIREMENT PROVIDED IN THIS SECTION. 5. A HEALTH SCREENING SHALL INCLUDE CLEAR DISCLOSURE THAT ADULT USE OF PSILOCYBIN UNDER THIS TITLE IS NOT TO TREAT ANY HEALTH CONDITIONS AND THE EXISTENCE OF HEALTH ASSESSMENTS AND TREATMENTS FOR ANY POTENTIAL HEALTH CONDITIONS. 6. A HEALTH SCREENING SHALL INCLUDE CLEAR DISCLOSURE THAT EXCLUSION CRITERIA IN CONNECTION WITH USE OF PSILOCYBIN MAY INCREASE SIGNIFICANT HEALTH AND SAFETY RISKS. 7. ANY INDICATION OF EXCLUSION CRITERIA SHALL DISQUALIFY A PERSON FROM A PSILOCYBIN PERMIT DUE TO HEALTH RISKS TO SUCH PERSON OR OTHERS. 8. A HEALTH SCREENING SHALL BE ALLOWED TO BE TAKEN IN AN ENTIRELY ONLINE FORMAT PROVIDED BY THE DEPARTMENT OR WITH A LICENSED HEALTHCARE PROVIDER, WHO SHALL THEN SUBMIT SUCH SCREENING TO THE DEPARTMENT. 9. THE PERMIT COURSE, WHICH SHALL BE NO LONGER THAN FIVE (5) HOURS AND ALLOWED TO BE TAKEN IN AN IN-PERSON OR ENTIRELY ONLINE FORMAT, SHALL PROVIDE THE APPROPRIATE EDUCATION AND INFORMATION ABOUT PSILOCYBIN AND PSILOCYBIN-CONTAINING FUNGI USING A CURRICULUM DEVELOPED BY THE DEPART- MENT REGARDING THE HISTORY OF INDIGENOUS, RELIGIOUS, AND CULTURAL USE, SAFETY, POTENCY AND EFFECTS OF DOSING AMOUNTS, CONTRAINDICATED HEALTH CONDITIONS AND SUBSTANCES, THE VALUE OF PREPARATION AND INTEGRATION, THE APPROPRIATE SETTING FOR USE, AND ANY MEDICALLY AVAILABLE EVIDENCE OF BENEFITS, HEALTH RISKS, AND THE SENSITIVITY PERIOD SUBSEQUENT TO PSILO- CYBIN USE, AND OPTIONAL SUPPORT SERVICES AVAILABLE, APPROPRIATE CONDUCT AND INFORMED CONSENT REQUIRED FOR SUCH SERVICES, AND THE DEPARTMENT REPORTING SYSTEM ESTABLISHED PURSUANT TO THIS TITLE. THE DEPARTMENT SHALL UPDATE THE CURRICULUM FOR THE PERMIT COURSE WITH MEDICALLY AVAIL- ABLE INFORMATION BIENNIALLY. 10. A PERMIT HOLDER MUST SUCCESSFULLY COMPLETE AN ABBREVIATED RENEWAL PERMIT COURSE BASED ON CHANGES TO THE CURRICULUM OR THIS TITLE EVERY FOUR YEARS TO MAINTAIN SUCH PERMIT HOLDER'S PERMIT. 11. THE COST OF THE PERMIT COURSE AND THE PERMIT APPLICATION SHALL NOT EXCEED REASONABLE, ACCESSIBLE FEES CONSISTENT WITH OTHER STATE PERMITS. A PERMIT COURSE SHALL NOT EXCEED ONE HUNDRED DOLLARS AND THE PERMIT APPLICATION SHALL NOT EXCEED EIGHTY DOLLARS. 12. THE DEPARTMENT MAY APPROVE A PERMIT COURSE DEVELOPED BY A PERSON OR BUSINESS ENTERPRISE THAT SATISFIES THE CURRICULUM REQUIREMENTS AND WILL PROVIDE CERTIFICATION THAT SUCH PERMIT COURSE, INCLUDING THE TEST, WAS SUCCESSFULLY COMPLETED TO THE DEPARTMENT. 13. A PSILOCYBIN PERMIT MAY BE GRANTED TO A CITIZEN OF ANY STATE, BUT SUCH RIGHTS GRANTED BY THE PSILOCYBIN PERMIT ONLY AUTHORIZE THE REGU- LATED ACTIVITIES IN THIS TITLE WITHIN THE STATE OF NEW YORK. 14. A PSILOCYBIN PERMIT HOLDER MAY ONLY LAWFULLY PURCHASE PSILOCYBIN FROM A LICENSED CULTIVATOR PURSUANT TO THIS TITLE, CULTIVATE THEIR OWN A. 10375 6 PSILOCYBIN, OR RECEIVE IT AS A NON-COMMERCIAL GIFT FROM ANOTHER PERMIT HOLDER. 15. PERMIT HOLDERS HAVE THE OPTION TO ENGAGE SUPPORT SERVICES PROVID- ERS FOR RISK REDUCTION SUPPORT SERVICES DURING ADULT USE OF PSILOCYBIN. 16. ADULT USE OF PSILOCYBIN SHALL NOT BE PERMITTED IN A PUBLIC LOCATION WITHIN FIVE HUNDRED FEET OF A SCHOOL GROUNDS. 17. A PERMIT HOLDER IS AUTHORIZED TO PURCHASE FROM A LICENSED CULTIVA- TOR, AS PROVIDED UNDER THIS TITLE, AN ALLOWABLE AMOUNT OF TWO OUNCES OF PROCESSED, DRIED PSILOCYBIN-CONTAINING FUNGI EACH CALENDAR MONTH. THE DEPARTMENT MAY INCREASE THIS ALLOWABLE AMOUNT. 18. MEASURING WEIGHT OF PSILOCYBIN-CONTAINING FUNGI FOR ADULT USE SHALL BE MEASURED BASED ON THE DRIED, PROCESSED CONDITION OF PSILOCY- BIN-CONTAINING FUNGI, AND DOES NOT INCLUDE THE WEIGHT OF ANY MATERIAL OF WHICH THE SUBSTANCE IS A PART OR TO WHICH THE SUBSTANCE IS ADDED, DISSOLVED, HELD IN SOLUTION, OR SUSPENDED, OR ANY INGREDIENT OR MATERIAL COMBINED WITH THE SUBSTANCE AS PART OF A PREPARATION. 19. A PERMIT HOLDER IS AUTHORIZED TO PERSONALLY CULTIVATE PSILOCYBIN- CONTAINING FUNGI IN A CULTIVATION SPACE THAT PRODUCES NO MORE THAN A LIMITED SPACE IN VOLUME, AS REGULATED BY THE DEPARTMENT, FOR ADULT USE OF PSILOCYBIN. NO PSILOCYBIN PERMIT HOLDER SHALL BE PENALIZED FOR POSSESSION IN EXCESS OF THE ALLOWABLE AMOUNT IF IT IS STORED IN A LOCKED CONTAINER WITHIN THEIR RESIDENCE FOR ADULT USE. NOTWITHSTANDING ANY PROVISION TO THE CONTRARY, PERSONAL CULTIVATION DOES NOT PERMIT COMMER- CIAL SALES OR RIGHTS GRANTED BY A CULTIVATION LICENSE. 20. A PERMIT HOLDER MAY PROVIDE PSILOCYBIN TO OTHER PERMIT HOLDERS ONLY IF THE PSILOCYBIN IS A NON-COMMERCIAL TRANSACTION AND A PSILOCYBIN PERMIT IS PROVIDED TO DEMONSTRATE AUTHORIZATION PURSUANT TO THIS TITLE. A PERMIT HOLDER IS PROHIBITED FROM THE TRANSFER OF PSILOCYBIN AS A REMUNERATED COMMERCIAL TRANSACTION UNLESS AUTHORIZED TO DO SO AS A LICENSED CULTIVATOR PURSUANT TO SECTION THREE THOUSAND THREE HUNDRED SIXTY-NINE-EE OF THIS TITLE. 21. A LICENSED HEALTHCARE PROVIDER MAY, WITHIN THE SCOPE OF SUCH HEALTHCARE PROVIDER'S PRACTICE, OFFER PROFESSIONAL SERVICES TO SUPPORT PATIENTS AND CLIENTS WHO ARE PERMIT HOLDERS IN SUCH PATIENTS' ADULT USE OF PSILOCYBIN WITH RESPECT TO THE HEALTH SCREENING OR IN PREPARATION OR SUBSEQUENT TO SUPPORT SERVICES. 22. PSILOCYBIN PERMIT HOLDERS WHO ARE IN VIOLATION OF THIS TITLE IN MORE THAN TWO INSTANCES MAY BE PENALIZED BY LOSS OF SUCH PERMIT FOR A PERIOD OF TWO YEARS AND, AFTER SUCH PENALIZATION PERIOD, SHALL SUBSE- QUENTLY BE ENTITLED TO APPLY FOR A PSILOCYBIN PERMIT. § 3369-DD. CERTIFICATION AND AUTHORIZED SERVICES OF SUPPORT SERVICES PROVIDER. 1. STATE-CERTIFIED SUPPORT SERVICES PROVIDERS MAY PROVIDE NON-MEDICAL, NON-THERAPEUTIC, AND NON-DIRECTIVE RISK REDUCTION SUPPORT SERVICES TO INCREASE THE HEALTH AND SAFETY OF A PERMIT HOLDER. 2. NO SUPPORT SERVICES CERTIFICATION ESTABLISHES ANY LICENSURE, CERTIFICATION, OR OTHER AUTHORITY TO PROVIDE THERAPY, COACHING, OR TREATMENT IN CONNECTION WITH ADULT USE OF PSILOCYBIN, BUT SUPPORT SERVICES PROVIDERS ARE NOT PRECLUDED FROM CONTRACTING OR PROVIDING SEPA- RATELY FOR SUCH SERVICES. 3. IN ORDER TO RECEIVE A SUPPORT SERVICES PROVIDER CERTIFICATION FROM THE DEPARTMENT, A PERSON SHALL COMPLETE A SUPPORT SERVICES TRAINING COURSE WITH A CURRICULUM AND WRITTEN EXAM THAT INCLUDES EDUCATION AND INFORMATION ABOUT PSILOCYBIN REGARDING ITS HISTORY OF INDIGENOUS USE AND CULTURAL RELEVANCE, BENEFITS AND HEALTH RISKS BASED ON CURRENTLY AVAIL- ABLE MEDICAL EVIDENCE, EFFECTS OF DOSING AMOUNTS, CONTRAINDICATED HEALTH CONDITIONS AND INTERACTING SUBSTANCES THAT INCREASE RISKS, INFORMED A. 10375 7 CONSENT, RISK REDUCTION STRATEGIES, AND ADVERSE EVENT AND EMERGENCY PROTOCOL, AS DETERMINED BY THE DEPARTMENT IN REGULATION. 4. THE COST OF ANY SUPPORT SERVICES TRAINING COURSE SHALL BE A REASON- ABLE, ACCESSIBLE AMOUNT AND NOT EXCEED ONE THOUSAND FIVE HUNDRED DOLLARS AND THE CERTIFICATION APPLICATION SHALL NOT EXCEED EIGHTY DOLLARS. 5. A SUPPORT SERVICES PROVIDER IS OBLIGATED TO PARTICIPATE IN BIENNIAL CONTINUED EDUCATION COURSES WITH A CURRICULUM DETERMINED BY THE DEPART- MENT IN REGULATION. 6. ANY TRAINING COURSE FOR SUPPORT SERVICES PROVIDERS SHALL BE AVAIL- ABLE FOR A REASONABLE FEE AND MAY BE PROVIDED ENTIRELY ONLINE TO CREATE AFFORDABILITY, ACCESSIBILITY, RECOGNIZE NEED FOR CULTURALLY COMPETENT RISK REDUCTION SUPPORT, AND DIVERSITY. 7. THE DEPARTMENT MAY APPROVE A SUPPORT SERVICES TRAINING COURSE DEVELOPED BY A PERSON OR BUSINESS ENTERPRISE THAT SATISFIES THE CURRIC- ULUM REQUIREMENTS UNDER THIS TITLE AND WILL PROVIDE CERTIFICATION THAT SUCH TRAINING COURSE, INCLUDING THE EXAM, WAS SUCCESSFULLY COMPLETED TO THE DEPARTMENT. 8. SUPPORT SERVICES PROVIDERS MAY PROVIDE SUPPORT SERVICES IN ANY LOCATION, AS DETERMINED BY THE DEPARTMENT AND TO CREATE ACCESSIBILITY, INCLUDING BUT NOT LIMITED TO APPROPRIATELY ZONED SETTINGS SUCH AS PRIVATE OFFICES AND COMMERCIAL USE, OR RESIDENCES OF THE PERMIT HOLDER OR THE SUPPORT SERVICES PROVIDER WHERE A HOME OCCUPATION IS ALLOWED. 9. THE DEPARTMENT SHALL DEVELOP AN INFORMED CONSENT DOCUMENT THAT MUST BE USED AND MAY BE MODIFIED TO INCLUDE ADDITIONAL BUT NOT CONFLICTING INFORMATION BY A SUPPORT SERVICES PROVIDER IN EACH INSTANCE OF PROVISION OF SUCH SERVICES TO A PSILOCYBIN PERMIT HOLDER. 10. ONE OR MORE SUPPORT SERVICES PROVIDERS MAY PROVIDE SUPPORT SERVICES TO ONE OR MORE PERMIT HOLDERS SIMULTANEOUSLY CONSISTENT WITH CERTAIN RULES, SUCH AS THE PROPORTION OF SERVICE PROVIDERS TO PERMIT HOLDERS, AS DETERMINED BY THE DEPARTMENT IN REGULATION. 11. A PERSON MAY, BUT SHALL NOT BE REQUIRED TO, HAVE A PSILOCYBIN PERMIT AND SUPPORT SERVICES CERTIFICATION CONCURRENTLY. 12. THE DEPARTMENT MAY ESTABLISH ADDITIONAL LEVELS OF CERTIFICATION PURSUANT TO RESEARCH AND MEDICAL STANDARDS. 13. THE DEPARTMENT SHALL CREATE A CERTIFICATION BOARD TO REVIEW SUPPORT SERVICES PROVIDER CERTIFICATION AND THE COMPLIANCE OF A SUPPORT SERVICES PROVIDER. 14. A SUPPORT SERVICES PROVIDER SHALL BE ENTITLED TO OFFER SUPPORT SERVICES IN EXCHANGE FOR COMPENSATION AS A COMMERCIAL TRANSACTION. 15. A SUPPORT SERVICES PROVIDER MAY ENGAGE IN THE COMMERCIAL TRANS- ACTION OF THEIR AUTHORIZED SUPPORT SERVICES UNDER THIS TITLE AND, IF A PERMIT HOLDER, SIMULTANEOUSLY ENGAGE IN THE NONCOMMERCIAL TRANSACTION OF GIFTING PSILOCYBIN TO THE PERMIT HOLDER ENGAGING SUCH PROVIDER FOR SUPPORT SERVICES. 16. A SUPPORT SERVICES PROVIDER SHALL REQUIRE CONFIRMATION OF A VALID PSILOCYBIN PERMIT AND REVIEW THE HEALTH SCREENING FORM PROVIDED BY THE PERMIT HOLDER ENGAGING SUPPORT SERVICES PRIOR TO PROVISION OF SERVICES DURING THE ADULT USE OF PSILOCYBIN AUTHORIZED UNDER THIS TITLE. A PERMIT HOLDER SHALL CONFIRM ACCURACY OF RESPONSES ON THE HEALTH SCREENING FORM BEFORE EACH INSTANCE OF SUPPORT SERVICES. 17. A SUPPORT SERVICES CERTIFICATION UNDER THIS TITLE SHALL NOT BE A PROFESSIONAL LICENSE UNDER THE EDUCATION LAW. 18. THE DEPARTMENT OF EDUCATION, THE DEPARTMENT, AND ANY APPLICABLE STATE LICENSING BOARDS MAY ESTABLISH CERTIFICATIONS, LICENSURE, OR RELATED REGULATIONS TO ALLOW A LICENSED PROFESSIONAL TO PROVIDE PROFES- SIONAL SERVICES SIMULTANEOUSLY WITH SUPPORT SERVICES WITH A SUPPORT A. 10375 8 SERVICES PROVIDER CERTIFICATION OR AS OTHERWISE DETERMINED IN REGU- LATION. 19. THIS TITLE SHALL ALLOW THE LICENSED PROFESSIONALS TO SHARE PATIENT-APPROVED INFORMATION WITH SUPPORT SERVICE PROVIDERS THROUGH LAWFUL DISCLOSURES AND AGREEMENTS, AS CONSISTENT WITH THE HEALTH INSUR- ANCE PORTABILITY AND ACCOUNTABILITY ACT, AS APPLICABLE. § 3369-EE. CULTIVATOR LICENSE AND REQUIREMENTS. 1. FOR THE PURPOSES OF THIS TITLE, PSILOCYBIN-CONTAINING FUNGI SHALL NOT CONSTITUTE A "FOOD," OR "FOOD PRODUCT," AS DEFINED AND REGULATED BY SECTION 161.21 OF TITLE ONE OF THE COMPILATION OF CODES, RULES, AND REGULATIONS OF THE STATE OF NEW YORK, TO BE DISTINGUISHED FROM FUNGI THAT DO NOT CONTAIN PSILOCYBIN THAT ARE CULTIVATED UNDER CONTROLLED CONDITIONS. 2. THE DEPARTMENT MAY ISSUE A CULTIVATOR LICENSE TO A CULTIVATOR OF PSILOCYBIN-CONTAINING FUNGI TO CULTIVATE AND ENGAGE IN COMMERCIAL TRANS- ACTIONS OF PSILOCYBIN-CONTAINING FUNGI CONSISTENT WITH THIS TITLE TO PSILOCYBIN PERMIT HOLDERS. CULTIVATION OF PSILOCYBIN-CONTAINING FUNGI INCLUDES PRODUCTION, MANUFACTURE, PROCESSING, AND REQUIRED TESTING AND DISCLOSURES. COMMERCIAL TRANSACTION OF PSILOCYBIN-CONTAINING FUNGI INCLUDE, SALE, DISTRIBUTION, AND DELIVERY. 3. TO OBTAIN A CULTIVATOR LICENSE, AN APPLICANT MUST SHOW ABILITY TO SATISFY THE REQUIREMENTS OF THIS SECTION. MAINTENANCE OF A CULTIVATOR LICENSE REQUIRES THE DEMONSTRATION OF THE SATISFACTION OF ALL REQUIRE- MENTS OF THIS SECTION AND ANY REGULATIONS PROMULGATED BY THE DEPARTMENT PURSUANT TO THIS SECTION. 4. A LICENSED CULTIVATOR MUST CULTIVATE PSILOCYBIN-CONTAINING FUNGI IN A PROPERLY ZONED AND LICENSED FACILITY APPROVED FOR CULTIVATION. PROC- ESSING AND PACKAGING OF PSILOCYBIN-CONTAINING FUNGI MUST BE PERFORMED IN A MANNER CONSISTENT WITH THE RELEVANT SAFETY REGULATIONS. PSILOCYBIN- CONTAINING FUNGI MUST BE STORED UNDER SANITARY CONDITIONS. 5. A LICENSED CULTIVATOR SHALL CULTIVATE PSILOCYBIN-CONTAINING FUNGI USING CONTROLLED CONDITIONS THAT ADHERE TO CURRENT FOOD SAFETY PROTOCOL IN ORDER TO REASONABLY REDUCE FUNGI CONTAMINANTS. 6. A LICENSED CULTIVATOR SHALL CLEARLY LABEL THE PSILOCYBIN-CONTAINING FUNGI WITH THE REQUIRED DISCLOSURES, INCLUDING THE FULL REGISTERED NAME OF THE LICENSED CULTIVATOR, SUCH CULTIVATOR'S OFFICE ADDRESS, A DESCRIPTION OF CONTENTS PROVIDING THE DISCLOSURE OF THE STRAIN, AND THE CULTURE-SPECIFIC APPROXIMATE PSILOCYBIN EQUIVALENT POTENCY OF THE PSILO- CYBIN-CONTAINING FUNGI. 7. A LICENSED CULTIVATOR SHALL ENGAGE IN ANNUAL TESTING FOR EACH CULTURE USED FOR CULTIVATION IN ORDER TO REASONABLY CONFIRM SATISFACTION OF ALL RELEVANT PROTOCOL, INCLUDING STRAIN AND POTENCY, THROUGH AUTHOR- IZED IN-STATE TESTING FACILITIES, AS REGULATED BY THE DEPARTMENT. ANY NEW CULTURES SHALL BE SUBJECT TO THE REQUIREMENTS OF THIS SECTION. 8. A LICENSED CULTIVATOR MAY SELL DIRECTLY TO PERMIT HOLDERS WITHIN AN INTRASTATE SYSTEM ESTABLISHED BY THE DEPARTMENT. SALES BY LICENSED CULTIVATORS MAY BE ACCOMPLISHED USING DIRECT TO CONSUMER DELIVERY SERVICES SOLELY TO PERMIT HOLDERS IN THE STATE. DELIVERIES MAY BE FACIL- ITATED BY CONTRACTING WITH ADDITIONAL PERSONS OR BUSINESS ENTERPRISES AND REMAIN AN AUTHORIZED ACTIVITY PURSUANT TO A CULTIVATOR LICENSE. 9. SALES SHALL NOT NEED TO BE THROUGH A DISPENSARY, HOWEVER THE DEPARTMENT MAY PROMULGATE RULES RELATED TO A DISPENSARY CONTRACTED WITH A LICENSED CULTIVATOR AND MEETS OTHER APPLICABLE REQUIREMENTS OF THIS TITLE. 10. ANY COMMERCIAL TRANSACTION REQUIRES PROVISION OF AN INFORMATIONAL DOCUMENT THAT GIVES INFORMATION ABOUT STRENGTH OF PSILOCYBIN-CONTAINING FUNGI AND DOSING AND IDENTIFIES OPTIONAL SUPPORT SERVICE PROVIDERS. A. 10375 9 11. ANY PERSON OR BUSINESS ENTERPRISE THAT IS CONTRACTED FOR SERVICES BY A LICENSED CULTIVATOR, FOR OR TO ACCOMPLISH AN AUTHORIZED ACTIVITY UNDER SUCH CULTIVATOR LICENSE, SUCH AS DELIVERY SERVICES TO PERMIT HOLD- ERS OR TESTING OF POTENCY, SHALL BE CONSIDERED A LICENSEE TO THE EXTENT OF THE PERFORMANCE OF THE CONTRACTED SERVICES AND SHALL NOT BE IN VIOLATION OF THIS TITLE. 12. LICENSED CULTIVATORS SHALL MAINTAIN SECURE STORAGE OF PSILOCYBIN PRIOR TO DISTRIBUTION TO PREVENT DIVERSION AND IN A MANNER THAT WILL MAINTAIN THE DISCLOSED POTENCY AND PREVENT CONTAMINATION. 13. LICENSED CULTIVATORS MUST MAINTAIN RECORDS OF ALL CULTIVATION PRODUCTION AND SALES. UPON REQUEST BY THE DEPARTMENT, LICENSED CULTIVA- TORS MUST PROVIDE THESE RECORDS AND ENGAGE IN ANNUAL INSPECTIONS. 14. THE DEPARTMENT SHALL MAINTAIN A REGISTRY OF CULTIVATORS WHO ARE LICENSED FOR PERMIT HOLDERS TO PURCHASE PSILOCYBIN-CONTAINING FUNGI. § 3369-FF. RELATION TO OTHER LAWS. 1. NOTHING UNDER THIS TITLE PERMITS OR AUTHORIZES THE PROMOTION OF USE OF PSILOCYBIN AS A DRUG, SUBSTANCE, OR PRODUCT INTENDED TO DIAGNOSE, TREAT, CURE, OR PREVENT ANY DISEASE OR MENTAL HEALTH OR OTHER HEALTH CONDITIONS. 2. SECTION THREE THOUSAND THREE HUNDRED SIX OF THIS ARTICLE SHALL BE AMENDED TO REMOVE "PSILOCYBIN" AND "PSILOCIN" FROM THE SCHEDULES OF CONTROLLED SUBSTANCES AND TO PROVIDE AN EXCEPTION FOR "PSILOCYBIN" AND "PSILOCIN" FROM "HALLUCINOGENIC SUBSTANCES". 3. FOR THE PURPOSES OF THIS TITLE, PSILOCYBIN AND PSILOCIN SHALL NOT BE DEEMED TO BE A "DRUG" FOR PURPOSES OF SUBDIVISION TWELVE OF SECTION THREE THOUSAND THREE HUNDRED TWO OF THIS ARTICLE. 4. FOR THE PURPOSES OF THIS TITLE, PSILOCYBIN-CONTAINING MUSHROOMS SHALL NOT BE DEEMED A FOOD OR FOOD PRODUCT UNDER THE AGRICULTURE AND MARKETS LAW. 5. FOR THE PURPOSES OF THIS TITLE, PSILOCYBIN SHALL NOT BE DEEMED TO BE A "DRUG" FOR PURPOSES OF ARTICLE ONE HUNDRED THIRTY-SEVEN OF THE EDUCATION LAW AND IS NOT INTENDED TO BE DISTRIBUTED THROUGH ANY PHARMA- CY. 6. TO USE, MANUFACTURE, DELIVER, SELL, OR DISTRIBUTE PSILOCYBIN WITH- OUT AUTHORIZATION BY PSILOCYBIN PERMIT OR CULTIVATOR LICENSE SHALL NOT EXCEED A FINDING OF A VIOLATION PURSUANT TO SECTION 55.10 OF THE PENAL LAW. 7. WHERE A PROVISION OF THIS TITLE CONFLICTS WITH ANOTHER PROVISION OF THIS CHAPTER, THIS TITLE SHALL APPLY. § 3369-GG. PROTECTIONS. 1. PSILOCYBIN PERMIT HOLDERS, LICENSED CULTI- VATORS, AND CERTIFIED SUPPORT SERVICES PROVIDERS SHALL NOT BE SUBJECT TO ARREST, PROSECUTION, OR PENALTY IN ANY MANNER, OR DENIED ANY RIGHT OR PRIVILEGE, INCLUDING BUT NOT LIMITED TO CIVIL PENALTY OR DISCIPLINARY ACTION BY A BUSINESS OR OCCUPATIONAL OR PROFESSIONAL LICENSING BOARD OR BUREAU, SOLELY FOR THE ADULT USE OF PSILOCYBIN OR FOR ANY OTHER ACTION OR CONDUCT IN ACCORDANCE WITH THIS TITLE. 2. AN APPLICANT OR HOLDER OF A PROFESSIONAL OR OCCUPATIONAL LICENSE, CERTIFICATION, OR REGISTRATION UNDER STATE LAW AND THROUGH A STATE DEPARTMENT SHALL NOT BE SUBJECT TO DISQUALIFICATION, DENIAL, SUSPENSION, REVOCATION, PROFESSIONAL DISCIPLINE, OR LOSS OF A PROFESSIONAL LICENSE OR CERTIFICATION FOR ANY ACTIVITIES AUTHORIZED UNDER THIS TITLE. 3. NO PERSON SHALL BE DISQUALIFIED FROM ANY AUTHORIZED RIGHTS, PROGRAMS, OR PROVISION OF THIS TITLE DUE TO A VIOLATION OF ANY FEDERAL OR STATE LAWS RELATING TO CONTROLLED SUBSTANCES. 4. A PROFESSIONAL OR OCCUPATIONAL LICENSEE OR ANY PERSON WITH LICEN- SURE, CERTIFICATION, OR REGISTRATION UNDER STATE LAW OR THROUGH A STATE DEPARTMENT SHALL HAVE THE RIGHT TO PROVIDE SERVICES WITHIN THE SCOPE OF A. 10375 10 SUCH LICENSE OR CERTIFICATION TO SUPPORT CLIENTS OR PATIENTS WHO ARE SEEKING TO BECOME OR ARE PSILOCYBIN PERMIT HOLDERS IN CONNECTION WITH CONDUCT AUTHORIZED UNDER THIS TITLE, INCLUDING BUT NOT LIMITED TO DISCUSSIONS WITH SUCH LICENSEE'S PATIENTS ABOUT THE POTENTIAL BENEFITS AND RISKS OF ADULT USE OF PSILOCYBIN. 5. THIS SUBDIVISION SHALL NOT BAR THE ENFORCEMENT OF A POLICY PROHIB- ITING AN EMPLOYEE FROM PERFORMING SUCH EMPLOYEE'S EMPLOYMENT DUTIES WHILE IMPAIRED BY A CONTROLLED SUBSTANCE. THIS SUBDIVISION SHALL NOT REQUIRE ANY PERSON OR BUSINESS ENTERPRISE TO ENGAGE IN ANY ACT THAT WOULD PUT THE PERSON OR BUSINESS ENTERPRISE IN DIRECT VIOLATION OF FEDERAL LAW OR CAUSE IT TO LOSE A FEDERAL CONTRACT OR FUNDING. 6. AN OTHERWISE ENFORCEABLE CONTRACT RELATED TO PROGRAMS OR ACTIVITIES AUTHORIZED UNDER THIS TITLE SHALL NOT BE UNENFORCEABLE ON THE BASIS OF STATE OR FEDERAL CONTROLLED SUBSTANCES LAWS. 7. USE OF PSILOCYBIN BY INGESTION MAY ONLY BE CONSIDERED TO CAUSE AN INTOXICATED STATE WHEN SUBSTANTIALLY IMPAIRED, AND ANY RELATED CONDUCT, INCLUDING DRIVING, SHALL BE REGULATED CONSISTENT WITH APPLICABLE STATE LAWS INCLUDING LAWS RESTRICTING DRIVING UNDER THE INFLUENCE. A DRUG SCREENING THAT CONTAINS POSITIVE RESULTS OF THE USE OF PSILOCYBIN IS NOT SUFFICIENT EVIDENCE TO DEMONSTRATE INTOXICATION WITHOUT OTHER CONDUCT THAT INDICATES IMPAIRMENT. 8. (A) THE FACT THAT A PERSON IS A PSILOCYBIN PERMIT HOLDER, A SUPPORT SERVICES PROVIDER, A LICENSED CULTIVATOR AND/OR ACTING IN ACCORDANCE WITH THIS TITLE SHALL NOT BE A CONSIDERATION IN A PROCEEDING PURSUANT TO APPLICABLE SECTIONS OF THE DOMESTIC RELATIONS LAW, THE FAMILY COURT ACT, OR THE SOCIAL SERVICES LAW. (B) CONDUCT PERMITTED BY THIS TITLE SHALL NOT, BY ITSELF: (I) CONSTITUTE CHILD ABUSE OR NEGLECT WITHOUT A FINDING OF ACTUAL THREAT TO THE HEALTH OR WELFARE OF A CHILD BASED ON ALL RELEVANT FACTORS; (II) BE THE BASIS TO RESTRICT PARENTING TIME WITH A CHILD WITHOUT FINDING THAT THE PARENTING TIME WOULD ENDANGER SUCH CHILD'S EMOTIONAL DEVELOPMENT; OR (III) BE THE BASIS TO DENY ELIGIBILITY FOR ANY PUBLIC ASSISTANCE PROGRAM, UNLESS REQUIRED BY FEDERAL LAW. 9. (A) INFORMATION CONTAINED IN ANY DATABASE CREATED AS PART OF THIS TITLE SHALL BE DEEMED EXEMPT FROM PUBLIC DISCLOSURE UNDER SECTIONS EIGHTY-SEVEN AND EIGHTY-NINE OF THE PUBLIC OFFICERS LAW. (B) THE NAME, CONTACT INFORMATION, AND OTHER INFORMATION RELATING TO SUPPORT SERVICES PROVIDERS REGISTERED WITH THE DEPARTMENT UNDER THIS TITLE SHALL BE PUBLIC INFORMATION AND SHALL BE MAINTAINED ON THE DEPART- MENT'S WEBSITE AND ACCESSIBLE TO THE PUBLIC IN SEARCHABLE FORM. HOWEV- ER, IF A SUPPORT SERVICES PROVIDER NOTIFIES THE DEPARTMENT IN WRITING THAT SUCH SUPPORT SERVICES PROVIDER DOES NOT WANT SUCH PROVIDER'S NAME AND OTHER INFORMATION DISCLOSED, SUCH SUPPORT SERVICES PROVIDER'S NAME AND OTHER INFORMATION SHALL THEREAFTER NOT BE PUBLIC INFORMATION OR MAINTAINED ON THE DEPARTMENT OF EDUCATION'S WEBSITE, UNLESS THE SUPPORT SERVICES PROVIDER CANCELS THE REQUEST. § 3369-HH. REGULATED PSILOCYBIN ADVISORY BOARD. 1. THE REGULATED PSILOCYBIN ADVISORY BOARD OR "ADVISORY BOARD" IS ESTABLISHED WITHIN THE DEPARTMENT TO ADVISE AND ISSUE RECOMMENDATIONS ON THE ADULT USE OF PSILOCYBIN AND ALL PROGRAMS UNDER THIS TITLE IN THE STATE OF NEW YORK. 2. THE ADVISORY BOARD SHALL CONSIST OF THIRTEEN VOTING APPOINTED MEMBERS, ALONG WITH THE FOLLOWING MEMBERS SERVING AS NON-VOTING EX-OFFI- CIO MEMBERS: (A) THE COMMISSIONER, OR THEIR DESIGNEE; AND (B) A REPRE- A. 10375 11 SENTATIVE FROM THE DEPARTMENT WHO IS FAMILIAR WITH PUBLIC HEALTH PROGRAMS AND PUBLIC HEALTH ACTIVITIES IN THE STATE. 3. THE GOVERNOR SHALL HAVE SEVEN APPOINTMENTS, AT LEAST ONE OF WHICH SHALL BE A MEMBER OF A FEDERAL OR STATE RECOGNIZED NATIVE AMERICAN TRIBE, THE TEMPORARY PRESIDENT OF THE SENATE AND THE SPEAKER OF THE ASSEMBLY SHALL EACH HAVE THREE APPOINTMENTS TO THE BOARD. ADVISORY BOARD MEMBERS SHALL HAVE STATEWIDE GEOGRAPHIC REPRESENTATION THAT IS BALANCED AND DIVERSE IN ITS COMPOSITION. APPOINTED MEMBERS SHALL HAVE AN EXPER- TISE IN AGRICULTURE AND MYCOLOGY, PUBLIC AND BEHAVIORAL HEALTH, PSILOCY- BIN-ASSISTED THERAPY RESEARCH, MENTAL HEALTH (INCLUDING PTSD, DEPRESSION AND ANXIETY), SUBSTANCE USE DISORDERS, PAIN MANAGEMENT, ACCESS TO CARE IN UNDERSERVED COMMUNITIES, VETERAN HEALTH CARE, POLICY OR LEGAL EXPER- TISE RELATED TO PSILOCYBIN, PHARMACOLOGY, OR HARM REDUCTION AND RISK REDUCTION TRAINING. 4. THE MEMBERS SHALL BE APPOINTED TO THE ADVISORY BOARD TO EACH SERVE FOUR-YEAR TERMS AND IN THE EVENT OF A VACANCY, THE VACANCY SHALL BE FILLED IN THE MANNER OF THE ORIGINAL APPOINTMENT FOR THE REMAINDER OF THE TERM. THE APPOINTED MEMBERS AND REPRESENTATIVES SHALL RECEIVE NO COMPENSATION FOR THEIR SERVICES BUT SHALL BE ALLOWED THEIR ACTUAL AND NECESSARY EXPENSES INCURRED IN THE PERFORMANCE OF THEIR DUTIES AS BOARD MEMBERS. 5. THE CHAIRPERSON OF THE ADVISORY BOARD AND THE VICE CHAIRPERSON SHALL BE ELECTED FROM AMONG THE MEMBERS OF THE ADVISORY BOARD BY THE MEMBERS OF SUCH ADVISORY BOARD. THE VICE CHAIRPERSON SHALL REPRESENT THE ADVISORY BOARD IN THE ABSENCE OF THE CHAIRPERSON AT ALL OFFICIAL ADVI- SORY BOARD FUNCTIONS. 6. THE ADVISORY BOARD SHALL ENACT, AND FROM TIME TO TIME MAY AMEND, BYLAWS OR RULES IN RELATION TO ITS MEETINGS AND THE TRANSACTION OF ITS BUSINESS. THE BOARD MAY ALSO ESTABLISH COMMITTEES AND SUBCOMMITTEES NECESSARY FOR THE OPERATION OF THE BOARD. THE ADVISORY BOARD SHALL WORK WITH ESTABLISHED RELIGIOUS, CULTURAL AND COMMUNITY-BASED PSILOCYBIN GROUPS AND CULTIVATORS ON RECOMMENDATIONS TO THE DEPARTMENT REGARDING GUIDELINES FOR SAFE AND EFFECTIVE SERVICES, SAFETY STANDARDS, INDUSTRY BEST PRACTICES, CODE OF PROFESSIONAL CONDUCT, EDUCATION, TRAINING, AND EXAMINATION FOR SUPPORT SERVICES PROVIDERS, PRODUCTION, AND LONG-TERM STRATEGIC PLANS FOR SERVICE. A MAJORITY OF THE TOTAL NUMBER OF VOTING MEMBERS WHICH THE BOARD WOULD HAVE WERE THERE NO VACANCIES, SHALL CONSTITUTE A QUORUM AND SHALL BE REQUIRED FOR THE BOARD TO CONDUCT BUSI- NESS. ALL MEETINGS OF THE ADVISORY BOARD SHALL BE CONDUCTED IN ACCORD- ANCE WITH THE PROVISIONS OF ARTICLE SEVEN OF THE PUBLIC OFFICERS LAW. (A) WITHIN THE FIRST TWO YEARS OF THE ESTABLISHMENT OF THE ADVISORY BOARD, THE BOARD SHALL MEET AT LEAST ONCE EVERY CALENDAR MONTH AT A TIME AND PLACE DETERMINED BY THE CHAIRPERSON OR A MAJORITY OF THE VOTING MEMBERS OF THE BOARD. AFTER THE FIRST TWO YEARS, THE ADVISORY BOARD SHALL MEET AT LEAST ONCE EVERY CALENDAR QUARTER AT A TIME AND PLACE DETERMINED BY THE CHAIRPERSON OR A MAJORITY OF THE VOTING MEMBERS OF THE BOARD. THE ADVISORY BOARD MAY ALSO MEET AT OTHER TIMES AND PLACES SPECI- FIED BY THE CALL OF THE CHAIRPERSON OR OF A MAJORITY OF THE VOTING MEMBERS OF THE BOARD. (B) AFTER THE FIRST YEAR OF THE IMPLEMENTATION OF THE PROGRAMS, THERE SHALL BE: (I) A PROGRAM AUDIT INCORPORATING PERMIT HOLDER OPTIONAL FEED- BACK THROUGH THE REPORTING PROGRAM; AND (II) A STATE AND INDEPENDENT REVIEW OF EFFICACY, EFFICIENCY, COST, AND EQUITY. THE AUDIT WILL INCLUDE CONSIDERATION OF WHETHER AND HOW TO EXPAND PSILOCYBIN ACCESS, INCLUDING ADDITIONAL CERTIFICATIONS AND LICENSES RELATING TO USE OF PSILOCYBIN IN A. 10375 12 CONNECTION WITH QUALIFYING HEALTH CONDITIONS AND PSILOCYBIN ASSISTED THERAPY. 7. THE ADVISORY BOARD SHALL HAVE THE FOLLOWING DUTIES: (A) PROVIDE ADVICE TO THE DEPARTMENT REGARDING THE PROVISIONS OF THIS TITLE AND MAKE RECOMMENDATIONS ON AVAILABLE MEDICAL, PSYCHOLOGICAL, SCIENTIFIC STUDIES, RESEARCH AND OTHER INFORMATION RELATING TO THE SAFE- TY OF USE OF PSILOCYBIN. (B) DETERMINE EXCLUSION CRITERIA TO PRECLUDE ISSUANCE OF PSILOCYBIN PERMITS. (C) MAKE RECOMMENDATIONS TO THE DEPARTMENT ON THE REQUIREMENTS, SPEC- IFICATIONS, AND GUIDELINES FOR PROVIDING SUPPORT SERVICES TO A PERMIT HOLDER. (D) MAKE RECOMMENDATIONS TO THE DEPARTMENT ON PUBLIC HEALTH AND SAFETY STANDARDS AND INDUSTRY BEST PRACTICES UNDER THIS TITLE. (E) DEVELOP A LONG-TERM STRATEGIC PLAN FOR ENSURING THAT PSILOCYBIN SERVICES IN THE STATE WILL BECOME AND REMAIN A SAFE, ACCESSIBLE AND AFFORDABLE THERAPEUTIC OPTION, INCLUDING IN THERAPEUTIC AND MEDICAL TREATMENTS, FOR ALL PERSONS EIGHTEEN YEARS OF AGE AND OLDER FOR WHOM PSILOCYBIN SERVICES MAY BE APPROPRIATE. (F) MONITOR AND STUDY FEDERAL LAWS, REGULATIONS AND POLICIES REGARDING PSILOCYBIN. § 3369-II. TAXATION OF PSILOCYBIN REGULATED ACTIVITIES. 1. NOTWITH- STANDING ANY LAWS TO THE CONTRARY, PERSONS OR BUSINESS ENTERPRISES WHO COLLECT ANY AMOUNTS OF MONIES UNDER THIS TITLE, INCLUDING BUT NOT LIMIT- ED TO FOR SUPPORT SERVICES, REMUNERATION FOR PSILOCYBIN PROPERLY DISTRIBUTED BY A LICENSED CULTIVATOR, AND FEES FOR COURSES, SHALL BE TAXED AS INCOME UNDER STATE LAW. 2. ANY EXPENSES INCURRED IN ANY BUSINESS OPERATED IN ACCORDANCE WITH THIS TITLE SHALL BE TREATED AS TAX-DEDUCTIBLE UNDER STATE LAW. 3. PROCEEDS AND FEES UNDER THIS TITLE SHALL BE USED TO SUPPORT THE COSTS OF THE DEPARTMENT TOWARDS ADMINISTRATION AND OTHER COSTS RELATING TO PROGRAMS PURSUANT TO THIS TITLE, INCLUDING BUT NOT LIMITED TO PUBLIC EDUCATION AND RISKS OF USING PSILOCYBIN. 4. THE DEPARTMENT SHALL ISSUE REGULATIONS TO IMPLEMENT AND IMPOSE THE TAX. § 2. This act shall take effect immediately.
Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.
Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.
Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.